0
0
More than 20 lakh individuals from tribal areas across India have been screened for sickle cell anaemia in the past eight years, according to Dr. N. Kalaiselvi, Director General of the Council of Scientific and Industrial Research (CSIR)1. This large-scale screening initiative is part of the ongoing national efforts to identify and manage the prevalence of sickle cell disease, which disproportionately affects tribal populations.
Speaking at a recent event, Dr. Kalaiselvi highlighted the significant progress made in the fight against sickle cell anaemia. The CSIR, along with various government agencies, has intensified its focus on early detection and intervention, particularly in regions with higher genetic susceptibility to the disease.
Sickle cell anaemia is a hereditary blood disorder that causes red blood cells to assume an abnormal, rigid, sickle shape, leading to various health complications. Tribal communities in India are among the most vulnerable groups, with a higher incidence of the disease compared to the general population.
The government has also been exploring new therapeutic options and incentives to encourage research and innovation in the field. Recently, a reward of Rs 10 crore was announced for the development of new drugs to treat sickle cell disease, underscoring the urgency and commitment to address this public health challenge.
Dr. Kalaiselvi emphasized the importance of continued awareness, screening, and research to reduce the disease burden and improve the quality of life for affected individuals.
Disclaimer: This article is based on information available as of June 28, 2025, and is intended for informational purposes only. For the latest updates and medical advice, please consult official health sources or a qualified healthcare professional.
